The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of ...

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

While anemia impacts nearly a quarter of the world's population ... marked by an inability to utilize stored iron due to ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

When the spleen enlarges to handle excess immune cells and inflammation, it can lead to discomfort, anemia, and a weakened ... company developing a pipeline of treatments and potential cures for ...

Anemia is highly prevalent in patients with ... human erythropoietin therapy in anemic patients with chronic kidney disease and concomitant heart disease have demonstrated a reduction in left ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Sickle cell anemia requires ... with sickle cell disease, and is sometimes used in children as young as 9 months old. This oral medication is considered a first-line treatment for sickle cell ...

Credit: Getty Images Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use. Burgeoning options for diabetic kidney disease give ...